Login / Signup

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines.

Elena CandelaFrancisco MarínJose Miguel Rivera-CaravacaNuria Vicente IbarraLuna CarrilloMaría Asunción Esteve-PastorTeresa LozanoManuel Jesús MacíasVicente PerniasMiriam SandínEsteban Orenes-PiñeroMiriam Quintana-GinerIgnacio HortelanoBeatriz VillamíaAndrea VelizMariano ValdésJuan Gabriel Martínez-MartínezJuan Miguel Ruiz-Nodar
Published in: PloS one (2018)
Despite current invasive management of NSTE-ACS, patients not receiving catheterization are at very high risk for under treatment with recommended drugs, including NADs. Their medium-term prognosis is poor, with high mortality. Patients treated with PCI receive better pharmacological management, with high use of NADs.
Keyphrases